Patrick M. Kinn, PharmD, MPH

Clinical Pharmacy Specialist
University of Iowa Hospitals & Clinics

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-847) Duration of Daptomycin and Ceftaroline Dual Therapy in Salvage Methicillin Resistant Staphylococcus aureus (MRSA) Bacteremia Prior to Monotherapy De-escalation
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1700) Benchmarking Clinical Outcomes by Antimicrobial Spectrum in Patients with Community-Acquired Pneumonia
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT

• (P-1753) Impact of a Microbiology Reporting Change on Treatment Selection and Clinical Outcomes for Organisms at Low-Risk for Significant AmpC Production
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT